Log out

Copyright © 2020 InvestorPlace Media, LLC. All rights reserved. 1125 N. Charles St, Baltimore, MD 21201.

Alphatec Holdings (ATEC)

$6.76 0.65 (10.64%)

18:44 EDT ATEC Stock Quote Delayed 30 Minutes

Volume:

Previous Close $6.76

Market Cap 286.50M

PE Ratio -9.14

EPS -0.74

Volume (Avg. Vol.) 1.33M

Day's Range 5.82 - 6.94

52-Week Range 2.19 - 7.93

Dividend & Yield N/A (N/A)

ATEC Stock Predictions, Articles, and Alphatec Holdings News

From InvestorPlace
From the Web

7 Exciting Stocks to Buy for Aggressive Investors

By Louis Navellier, Editor, Growth Investor Feb 13, 2020

These aggressive stocks to buy have had roaring success in the last year and are set to continue gaining in 2020.

7 Healthcare Stocks With 100% Street Support

By Maya Sasson, Writer, TipRanks Jan 22, 2020

When searching for massive gains that can be achieved in the blink of an eye, look no further than healthcare stocks. Here are seven that stand out according to the Street.

Western Refining, Inc. (WNR) Signet Jewelers Ltd. (SIG) Leads 16 Activist Investor Filings

By Fintel Jun 2, 2017

13D and 13G filings are windows into activist investor activity. Today we focus on Western Digital and 15 other filings

3 Big Pharma Stocks With Surprising Cannabis Connections

From The Motley Fool Aug 8, 2020

These pharmaceutical giants are already preparing for the possibility of medical marijuana legalization.

Theravance (TBPH) Earnings & Revenues Miss Estimates in Q2

From Zacks Investment Research Aug 7, 2020

Theravance (TBPH) reports worse-than-expected loss for the second quarter while revenues too miss the mark. The company reiterates its 2020 outlook.

Pharma ETFs Soar on Robust Q2 Earnings

From Zacks Investment Research Aug 7, 2020

Total earnings of 66.4% of the healthcare market capitalization that has reported so far are up 4.4% on revenue growth of 4%.

Pharma Stock Roundup: ABBV, MRK Q2 Earnings & Coronavirus Updates in Focus

From Zacks Investment Research Aug 7, 2020

Sanofi (SNY)/Glaxo (GSK) and J&J (JNJ) sign deals with U.S. government for coronavirus vaccine candidate. Several drugmakers announce second-quarter results.

Technical Short Put Spread Fade the Dip Trade and Trigger in Johnson & Johnson

From Capital Market Laboratories Aug 7, 2020

The Techncial Trigger Driven Option Trade Right Before Johnson & Johnson (NYSE:JNJ) Earnings.

"We Have a Health Disparities Problem in America": Meet a Woman on a Mission to Improve Healthcare for Black Women

From 3BL Media Aug 7, 2020

SOURCE: Johnson & Johnson

Navellier Ratings

Powered by Portfolio Grader

Total Grade

B

Buy